Kilpinen, S., et al., Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues. Genome Biology, 9:R139, 2008.

 

Autio, R., et al., Comparison of Affymetrix data normalization methods using 6,926 experiments across five array generations. BMC Bioinformatics, 2009. 10 Suppl 1: p. S24.

 

Kilpinen S, Ojala K, Kallioniemi O (2010) Analysis of gene expression patterns across 5,681 human tissue samples reveals functional genomic taxonomy of the kinome. Plos One, 2010. 5(12): e15068.

 

Ojala KA, Kilpinen SK, Kallioniemi OP (2011) Classification of unknown primary tumors with a data-driven method based on a large microarray reference database. Genome Med., 2011. 3(9):63

 

Sundvall, M., et al., Role of ErbB4 in breast cancer. J Mammary Gland Biol Neoplasia, 2008. 13(2): p. 259-68.

 

Brennan, D.J., et al., The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer. Eur J Cancer, 2009. 45(8): p. 1510-7.

 

Wolf, M., et al., Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication. BMC Cancer, 2010. 10: p. 181.

 

Nevo, J., et al., Mammary-derived growth inhibitor alters traffic of EGFR and induces a novel form of cetuximab resistance. Clin Cancer Res, 2009. 15(21): p. 6570-81.

 

Iljin, K., et al., TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming. Cancer Res, 2006. 66(21): p. 10242-6.

 

Magnusson, K., et al., SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas. Am J Surg Pathol, 2011. 35(7): p. 937-948.

 

Vainio, P., et al., Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer. Am J Pathol, 2011. 178(2): p. 525-36.

 

Haapa-Paananen, S., et al., HES6 gene is selectively overexpressed in glioma and represents an important transcriptional regulator of glioma proliferation. Oncogene, 2011.

 

Rantala, JK., et al., Integrative functional genomics analaysis of sustained polyploidy phenotypes in breast cancer cells identifies an oncogenic profile for GINS2. Neoplasia, 2010. 12(11): p. 877-88.

 

Sugiyama, N., et al., Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation. Cancer Res, 2010. 70(20): 7851-61.